Schedule A Free Consultation What is Tirzepatide
41 (Suppl 1):S86-s104 3
MeAgain gives you that daily lens without replacing medical care, turning the work of protecting muscle and avoiding severe constipation into a playful routine with an adorable capybara that nudges protein, fiber, water, and exercise goals and a Journey Card to record milestones, so explore MeAgain if you want a clearer picture of how your body responds.
Related evidence from GLP-1 combinations The closest available data comes from studies of other GLP-1 agonists combined with phentermine
Key highlights Tirzepatide is the first dual GLP-1/GIP receptor agonist that offers stronger appetite suppression, improved glycemic control, and provides significantly greater weight loss than single receptor agonists such as semaglutide, liraglutide, and dulaglutide
In addition, it has not been studied in patients with pancreatitis